市場調查報告書
商品編碼
1078124
心臟生物標記的全球市場(2022年~2028年)Global Cardiac Biomarker Market 2022-2028 |
全球心臟生物標記的市場規模在預測期間內預計將以年複合成長率7.8%成長。由於心血管疾病患病率上升、老年人口增加和技術進步等因素,該市場正在全球擴張。
本報告提供全球心臟生物標記市場相關調查分析,提供市場概要,競爭情形,市場區隔分析,地區分析等資訊。
Cardiac Biomarker Market by Type (Creatine Kinase, Troponins, Myoglobin, Ischemia Modified Albumin, and Others), By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others), by Location of Testing (Laboratory Testing and Point of Care Testing) - Global Industry Share, Growth, Competitive Analysis and Forecast Period 2022-2028
The globalcardiac biomarker market is anticipated to grow at a CAGR of 7.8%during the forecast period. Cardiac biomarkers are substances that are discharged into the blood when the heart is harmed or focused. Estimations of these biomarkers are utilized to analyze acute coronary syndrome (ACS) and cardiac ischemia, and conditions related to lack of bloodstream to the heart. Tests for cardiac biomarkers help measure an individual's risk condition or screen and oversee an individual suspected ofACS and cardiac ischemia.
Several drivers are driving the cardiac biomarker market globally such as a rise in cardiovascular diseases, a rise in the geriatric population, and technological development. The rise in the geriatric population and the rise in cardiac vascular diseases are the major factors that affect the growth of the market as the biomarkers are utilized for detection of the cardiac problems. According to the CDC,one person dies every 36 seconds in the US from cardiovascular disease. About 659,000 people in the US die from heart disease each year-that's 1 in every 4 deaths. Heart disease costs the US about $363 billion each year from 2016 to 2017.
Cardiac biomarkers providean instant and accurate prediction of heart failure after chest pain, and these factors fuel the growth of the market. The market is also affected by the technological development of cardiac biomarkers. Consumption of tobacco or change in lifestyleis other factors that lead to an increase in cardiovascular diseases. According to the American heart association, that heart disease remains the prior cause of mortality in the US.
The cardiac biomarker has been segmented based on type,application, and location of testing. By type, the market issegmented into Creatine Kinase(CK-MB), troponins (T,I), myoglobin, natriuretic peptides( BNP& NT-proBNP), ischemia-modified albumin, and others. Based on application, the market issegmented into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis, and others. Based onthe location of testing, the market is segmented intopoint of care(POC) testing and laboratory testing.
Geographically, the worldwide cardiac biomarkershowcase is divided into North America, Europe, Asia-Pacific, and the Rest of the World.The Asia-Pacificmarket is considered to be the fastest-growing market globally.The rise in the number of cardiovascular patients in the Asia-Pacific region is considered to rise eventually enabling the cardiac biomarker market to grow. North America and Europe are considered to be the dominating markets due to various factors such as high healthcare expenditure, development in the technology, support from the government, and rise in the key players.
Some of the key players in the cardiac biomarker market include Abbott Laboratories Inc., Becton, Dickson & Co., Bio-Rad Laboratories, Randox Laboratories Ltd., Siemens AG, and Thermo Fisher Scientific Inc., among others.
Research Methodology
The market study of the global cardiac biomarker market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report provides an in-depth analysis of the market size andintended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
OMR Report Covers:
Category- Biotechnology
.2.1. By Segments